EnerSyn Global Inc. (ESYN)
ESYNNASDAQ-CMOther Pharmaceuticals
$1.50
-0.0350 (-2.28%) today
At the close, Nov 10, 4:00 PM ET. After hours $1.50 –
- Market cap
- $44.59m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- $1.32 to $1.52
- 52-week range
- $0.8800 to $2.81
- Average volume
- 45.9k
- Previous close
- $1.54
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | $207.0k | $55.0k | $64.0k | $64.0k |
| Gross profit | $344.0k | $40.0k | $47.0k | -$21.0k |
| Operating income | -$246.0k | -$2.01m | -$625.0k | -$229.0k |
| Net income | -$290.0k | -$1.94m | -$624.0k | $218.0k |
Last four quarters: revenue $390.0k, margin -675.9%, free cash flow –
News
3 latest- $HWH stock is up 28% today. Here's what we see in our data.Quiver Quantitative · May 14, 2025
- HWH International Inc. Announces 1-for-5 Reverse Stock Split Effective February 24, 2025Quiver Quantitative · Feb 20, 2025
- HWH International Inc. Completes Public Offering Raising $1.76 MillionQuiver Quantitative · Jan 6, 2025
The company
Previously known as HWH International Inc., the Company operates as a purpose-driven lifestyle company encompassing differentiated offerings to develop new pathways to help people in their pursuit of Health, Wealth and Happiness. The Company's management team has begun to evaluate a range of additional growth and investment opportunities that it believes can build long-term shareholder value and drive strong, sustainable growth. The Company intends to pursue such opportunities selectively and prudently, in a manner management deems beneficial to, and aligned with the long-term interests of its stockholders. The Company believes that energy represents a new addition to the Company that may provide favorable opportunities.
- Sector
- Health Care
- Industry
- Other Pharmaceuticals
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- hwhintl.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.